Cargando…
S267: PHARMACOKINETICS/PHARMACODYNAMICS, SAFETY AND EFFICACY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE AGED 12 TO <18 YEARS: 2-YEAR DATA FROM THE PHASE 2 SOLACE-KIDS STUDY
Autores principales: | Heeney1, Matthew, Rees, David, de Montalembert, Mariane, Odame, Isaac, Wali, Yasser, Sayyed, Sarfaraz, Shanmuganathan Muthusamy, Velusamy, Mendonza, Anisha E., Nassin, Michele, Keefe, Deborah, Kanter, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428338/ http://dx.doi.org/10.1097/01.HS9.0000967980.32472.94 |
Ejemplares similares
-
S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL
por: Heeney, M, et al.
Publicado: (2022) -
PB2512: SAFETY OF CRIZANLIZUMAB IN PATIENTS WITH SICKLE CELL DISEASE: INTEGRATED POST-MARKETING SURVEILLANCE ANALYSIS
por: Abboud, Miguel, et al.
Publicado: (2023) -
Grief and Solace
por: Kaiser, Robert M.
Publicado: (2020) -
Solace : a Mexican serenade : brass quintet /
por: Joplin, Scott, 1868-1917
Publicado: (1989) -
A quantum of solace
Publicado: (2009)